Optibiotix back in the black!

I couldn't wait until weekend to post as I'm bouncing up and down like a bouncy thing.

There's always a risk it will have turned around by weekend so I want to make sure I get an opportunity to sing from the rooftops that after plunging to horrible lows 3 weeks ago with a paper loss of £20,000, OPTI:Optibiotix is today sitting at a bid price of 69p and paper profits of £2,783.

In those three weeks my portfolio value has gone from £64,907 to £91,102. That's an increase of £26,000.

I do believe I was saying that I was sure when the craziness was over, OPTI would rocket, and it has.

That's why I bought a load more at 46p, which have increased by exactly 50%.

Given the relentless great news that has been flowing over the last few months, and the industry awards being won on a regular basis, even now the shares seem ridiculously cheap.

The thing that's most exciting about being an OPTI shareholder is that we've not yet seen the really big news. Despite everything that we already have all over the world, we've not even started commercialising LPGOS or Sweetbiotix.

LPGOS has been found to improve the performance of existing probiotics, including our own LP-LDL and the most widely sold probiotic LGG.

Sweetbiotix is a calorie-free fibre that tastes like sugar and has none of the dodgy aftertaste or potential side-effects of artificial sweeteners.

Even if we didn't already have Slimbiome and LP-LDL winning awards, getting kite marks, being certified as safe in foods and with production facilities suitable for pharma, we'd still justify the current share price on LPGOS and Sweetbiotix alone.

Oh - and we own about 37% of SBTX:SkinBioTherapeutics which is on the verge of signing a commercial deal with a global corporation, and have been promised a percentage of this as a dividend payout when some of those shares are placed with an institution.

It's been very distressing watching my portfolio being utterly hammered, especially when it sank to below the amount of cash I'd put in. At no point in that difficult period did I want to do anything other than buy more OPTI:Optibiotix shares. I didn't have that much ammunition, and had to sell 40% of my holding in CAML:Central Asia Metals at a small loss to do it, but the last three weeks have seen that loss well and truly recovered.

I only needed 3,000 to get past 100,000 shares, so my purchase at 46p was £1,391p. Even so, making £684 on these shares in a few weeks is a lot better than the £103 I would have made on a 14p increase in CAML:Central Asia Metals since then.

Add to that the remainder of the CAML sale went on SBTX and is £400 up.

I don't usually time things very well, but that seems to have worked out.

Let's look at the charts for the combined accounts...

What a climb! Much nearer to cost of portfolio than it is to initial cash injection.

The trend line is smashed through and is being tugged back towards the flat.

They do say pride comes before a fall, so I may still end up writing Friday's post in a state of utter misery, but I don't care because I've waited a long time to be happy about something in my portfolio, and I want to enjoy being happy even if it's just for a day.